JP2022517827A5 - - Google Patents

Info

Publication number
JP2022517827A5
JP2022517827A5 JP2021542097A JP2021542097A JP2022517827A5 JP 2022517827 A5 JP2022517827 A5 JP 2022517827A5 JP 2021542097 A JP2021542097 A JP 2021542097A JP 2021542097 A JP2021542097 A JP 2021542097A JP 2022517827 A5 JP2022517827 A5 JP 2022517827A5
Authority
JP
Japan
Prior art keywords
interest
molecule
roi
biological sample
exposed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021542097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517827A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/051388 external-priority patent/WO2020152151A1/en
Publication of JP2022517827A publication Critical patent/JP2022517827A/ja
Publication of JP2022517827A5 publication Critical patent/JP2022517827A5/ja
Pending legal-status Critical Current

Links

JP2021542097A 2019-01-22 2020-01-21 生物学的サンプル中の分子効果に関連する分子変化を評価するための方法 Pending JP2022517827A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305081 2019-01-22
EP19305081.2 2019-01-22
PCT/EP2020/051388 WO2020152151A1 (en) 2019-01-22 2020-01-21 Method for evaluating molecular changes related to a molecule effect in a biological sample

Publications (2)

Publication Number Publication Date
JP2022517827A JP2022517827A (ja) 2022-03-10
JP2022517827A5 true JP2022517827A5 (enExample) 2024-06-18

Family

ID=65494061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542097A Pending JP2022517827A (ja) 2019-01-22 2020-01-21 生物学的サンプル中の分子効果に関連する分子変化を評価するための方法

Country Status (6)

Country Link
US (1) US20220137027A1 (enExample)
EP (1) EP3914911A1 (enExample)
JP (1) JP2022517827A (enExample)
CN (1) CN113330312B (enExample)
CA (1) CA3125695A1 (enExample)
WO (1) WO2020152151A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115541692A (zh) * 2022-10-20 2022-12-30 中国科学院兰州化学物理研究所 一种同时分析小扁豆萌发过程中多种脂类成分空间分布变化的质谱成像方法
WO2024185286A1 (ja) * 2023-03-07 2024-09-12 株式会社島津製作所 イメージング質量分析を用いた解析方法
CN117740919A (zh) * 2023-11-27 2024-03-22 中国科学院深圳先进技术研究院 一种肿瘤类器官空间成像表征方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8229194B2 (en) * 2006-11-16 2012-07-24 Visiopharm A/S Feature-based registration of sectional images
AU2009258038A1 (en) * 2008-03-14 2009-12-17 Eastern Virginia Medical School Imaging mass spectrometry for improved prostate cancer diagnostics
CN101975818B (zh) * 2010-04-29 2012-12-26 中国计量科学研究院 特征物质的检测系统及方法
FR2973112B1 (fr) * 2011-03-21 2018-05-25 Imabiotech Procede de detection et de quantification d'une molecule cible dans un echantillon
US20150262329A1 (en) * 2012-10-03 2015-09-17 KONINKLIJKE PHILIPS N.V. a corporation Combined sample examinations
WO2014078374A2 (en) * 2012-11-13 2014-05-22 Presage Biosciences, Inc. Methods for multiplexed drug evaluation
CA2899994C (en) * 2013-02-25 2022-08-30 Imabiotech Method to evaluate the tissue targeting of a molecule of interest
CA2947650C (en) * 2014-05-29 2021-04-27 Spring Bioscience Corporation Anti- indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof
GB201413162D0 (en) * 2014-07-24 2014-09-10 Immusmol Sas Prediction of cancer treatment based on determination of enzymes or metabolites of the kynurenine pathway
FR3025317B1 (fr) * 2014-08-26 2022-09-23 Imabiotech Methode de caracterisation d'un echantillon par imagerie par spectrometrie de masse
CA3182538C (en) * 2015-06-11 2026-05-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio Systems and methods for finding regions of interest in hematoxylin and eosin (h&e) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue images
WO2017049403A1 (en) * 2015-09-22 2017-03-30 University Health Network System and method for optimized mass spectrometry analysis
US10609324B2 (en) * 2016-07-18 2020-03-31 Snap Inc. Real time painting of a video stream
CN107424156B (zh) * 2017-06-28 2019-12-06 北京航空航天大学 基于仿仓鸮眼视觉注意的无人机自主编队精准测量方法

Similar Documents

Publication Publication Date Title
Kalinina et al. Proteomics of gliomas: initial biomarker discovery and evolution of technology
Bodzon‐Kulakowska et al. Imaging mass spectrometry: instrumentation, applications, and combination with other visualization techniques
Lin et al. Precision biomarker discovery powered by microscopy image fusion-assisted high spatial resolution ambient ionization mass spectrometry imaging
JP6670288B2 (ja) 化学療法標的に対するsrmアッセイ
Patel Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders
WO2017150681A1 (ja) シグナルペプチドを指標にした筋萎縮性側索硬化症の診断方法
JP6612414B2 (ja) Pd−l1に対するsrmアッセイ
KR101384211B1 (ko) 췌장암 진단용 마커 및 이의 용도
Zubair MALDI mass Spectrometry based proteomics for drug discovery & development
CN113330312B (zh) 评估生物样品中与分子效应相关的分子变化的方法
JPWO2017150680A1 (ja) シグナルペプチドを指標にしたアルツハイマー病の診断方法
Downes et al. Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review
Fang et al. Recent advances in capillary electrophoresis‐based proteomic techniques for biomarker discovery
Loo et al. Proteomics in molecular diagnosis: typing of amyloidosis
US20180284126A1 (en) A method of detecting molecules in proximity to a target molecule in a sample
CN116165385B (zh) 用于肝癌诊断的血清代谢标志物及其筛选方法和应用
JP2024120022A (ja) 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
Huang et al. Rapid mass spectrometry imaging to assess the biochemical profile of pituitary tissue for potential intraoperative usage
JP5429725B1 (ja) 前立腺癌の進行度の評価方法、前立腺癌の検出方法、および検査キット
KR102136643B1 (ko) 신규한 간암 진단 마커 및 이의 용도
Roblick et al. Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis
Orme et al. A multiplexed quantitative proteomics approach for investigating protein expression in the developing central nervous system
Li et al. Development and validation of an LC-MS/MS method for the quantification of fascin proteins in human serum
Govorun et al. Proteomics and peptidomics in fundamental and applied medical studies
CN117589991B (zh) 一种用于乳腺癌患者her2表达状态鉴定的生物标志物、模型、试剂盒及用途